| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Rhythm Pharmaceuticals Inc (NASDAQ: RYTM)
RYTM Technical Analysis
4
| As on 9th Jun 2023 RYTM STOCK Price closed @ 17.43 and we RECOMMEND Buy for LONG-TERM with Stoploss of 13.26 & Strong Buy for SHORT-TERM with Stoploss of 8.55 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RYTMSTOCK Price
| Open | 17.58 | Change | Price | % |
| High | 17.77 | 1 Day | -0.17 | -0.97 |
| Low | 17.17 | 1 Week | 0.77 | 4.62 |
| Close | 17.43 | 1 Month | -2.50 | -12.54 |
| Volume | 325300 | 1 Year | 5.94 | 51.70 |
| 52 Week High 34.24 | 52 Week Low 3.12 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| RYTM Daily Charts |
RYTM Intraday Charts |
Whats New @ Bazaartrend |
RYTM Free Analysis |
|
|
RYTM Important Levels Intraday
| RESISTANCE | 18.59 |
| RESISTANCE | 18.22 |
| RESISTANCE | 17.99 |
| RESISTANCE | 17.76 |
| SUPPORT | 17.10 |
| SUPPORT | 16.87 |
| SUPPORT | 16.64 |
| SUPPORT | 16.27 |
RYTM Forecast May 2024
| 4th UP Forecast | 24.35 |
| 3rd UP Forecast | 22.13 |
| 2nd UP Forecast | 20.76 |
| 1st UP Forecast | 19.39 |
| 1st DOWN Forecast | 15.47 |
| 2nd DOWN Forecast | 14.1 |
| 3rd DOWN Forecast | 12.73 |
| 4th DOWN Forecast | 10.51 |
RYTM Weekly Forecast
| 4th UP Forecast | 22.25 |
| 3rd UP Forecast | 20.70 |
| 2nd UP Forecast | 19.75 |
| 1st UP Forecast | 18.79 |
| 1st DOWN Forecast | 16.07 |
| 2nd DOWN Forecast | 15.11 |
| 3rd DOWN Forecast | 14.16 |
| 4th DOWN Forecast | 12.61 |
RYTM Forecast2024
| 4th UP Forecast | 79 |
| 3rd UP Forecast | 59.25 |
| 2nd UP Forecast | 47.05 |
| 1st UP Forecast | 34.84 |
| 1st DOWN Forecast | 0.02 |
| 2nd DOWN Forecast | -12.19 |
| 3rd DOWN Forecast | -24.39 |
| 4th DOWN Forecast | -44.14 |
Rhythm Pharmaceuticals Inc ( NASDAQ USA Symbol : RYTM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RYTM Business Profile
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is also developing setmelanotide, which is in Phase II clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, Smith-Magenis syndrome obesity, POMC epigenetic disorders, and other MC4R disorders. Rhythm Pharmaceuticals, Inc. has a collaborative research agreement with the Clinical Registry Investigating Bardet-Biedl Syndrome. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. Address: 222 Berkeley Street, Boston, MA, United States, 02116
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service